Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials.
Saved in:
| Title: | Deucravacitinib: Laboratory Parameters Across Phase 3 Plaque Psoriasis Trials. |
|---|---|
| Authors: | Armstrong, April W.1 (AUTHOR) skinstudy@mednet.ucla.com, Kircik, Leon2 (AUTHOR), Stein Gold, Linda3 (AUTHOR), Strober, Bruce4 (AUTHOR), De Oliveira, Claudia H. M. C.5 (AUTHOR), Vaile, John5 (AUTHOR), Jou, Ying-Ming5 (AUTHOR), Daamen, Carolin5 (AUTHOR), Scharnitz, Thomas5 (AUTHOR), Lebwohl, Mark2 (AUTHOR) |
| Source: | Dermatology & Therapy. Apr2025, Vol. 15 Issue 4, p1025-1035. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 21938210 |
|---|---|
| DOI: | 10.1007/s13555-025-01362-w |